The global repositioning and offloading devices market size is calculated at USD 3.24 billion in 2024, grew to USD 3.43 billion in 2025 and is projected to surpass around USD 5.76 billion by 2034. The market is expanding at a CAGR of 5.92% between 2024 and 2034. The North America repositioning and offloading devices market size is evaluated at USD 1.17 billion in 2024 and is expected to grow at a CAGR of 6.05% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Repositioning and Offloading Devices Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Repositioning and Offloading Devices Market Revenue and Volume, by Product Type, 2024-2034
8.1.1 Nonremovable Knee-High Offloading Devices
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Removable Knee-High Offloading Devices
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Air-Assisted Lateral Transfer Systems
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Replacement Sliding Sheets
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Wheelchairs
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Repositioning and Offloading Devices Market Revenue and Volume, by Application, 2024-2034
9.1.1. Surgery
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Diagnostics
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Repositioning and Offloading Devices Market Revenue and Volume, by End user, 2024-2034
10.1.1. Hospitals
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Ambulatory Care
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Home Care Setting
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1.4. Nursing Homes
10.1.4.1. Market Revenue and Volume Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by End user (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by End user (2021-2034)
12.1. Stryker
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Medline Industries, LP
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Hill-Rom Services
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Frontier Medical Group
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Walgreen Health Solutions LLC
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Arjo Group
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Next Health LLC
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sage Products LLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Seneca Devices Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Guldmann
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client